MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

Jonnie R Williams, MyMD: A patent of astonishing range just allowed

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220339147

In paragraph [0012] note the breadth of coverage - far beyond "visual system"

Patent Application Publication ao) Pub. No.: US 2022/0339147 Al
Williams Pub. Date: Oct. 27,2022

METHOD OF TREATING DISEASES OF THE VISUAL SYSTEM

SUMMARY

[0009] In some aspects, a method of regulating oxidoreductase activity for treating an inflammation or age-related disorder comprises administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor. In some examples, the inflammation-related disorder is a parasitic infection or disease such as malaria. In other examples, the inflammation-related disorder is a bacterial infection or disease such as Lyme disease.

[0010] In other examples, a method of treating oxidative stress associated with an inflammation or age-related disor­der comprises administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceu­tically acceptable vehicle therefor.

[0011] In yet other examples, a method of reducing oxi­dative stress in an individual suffering from an inflammation or age-related disorder comprises administering to the indi­vidual a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.

[0012] In other aspects, a method of treating a disorder comprises administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, where the disorder is selected from the group consisting of infectious or parasitic diseases; neoplasms; diseases of the blood or blood-forming organs; diseases of the immune system; endocrine; nutri­tional or metabolic diseases; mental, behavioral or neurodevelopmental disorders; sleep-wake disorders; diseases of the nervous system; diseases of the visual system; diseases of the ear or mastoid process; diseases of the circulatory system; diseases of the respiratory system; diseases of the digestive system; diseases of the skin; diseases of the musculoskeletal system or connective tissue; diseases of the genitourinary system; conditions related to sexual health; pregnancy, childbirth or the puerperium; conditions origi­nating in the perinatal period; developmental anomalies; and injury ,poisoning or other consequences of external causes. In one example, a behavioral or neurodevelopmental disor­der is anxiety. In another example, a behavioral or neurode­velopmental disorder is depression.

***

A closely related patent:
Patent Application Publication (io)Pub. No.: US 2020/0338061 Al

Jonnie R Williams Pub.Date: Oct. 29,2020

METHODS OF REGULATING OXIDOREDUCTASE ACTIVITY FOR
TREATMENT OF INFLAMMATION AND AGE-RELATED DISORDERS

Applicant: MyMD Pharmaceuticals, Inc., Tampa, FL (US)